
Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
A leading global pharmaceutical organisation seeks a Global RWE & Health Outcomes Research Analyst to develop asset-level real-world evidence strategies. This role supports a high-visibility global asset and involves collaboration across various functions including Medical Affairs and Market Access. The ideal candidate will have an MSc in a relevant field and experience in RWE and non-interventional studies within the pharmaceutical sector. The position offers a hybrid working model in the United Kingdom and opportunities for career growth.
Location: Homebased / Hybrid
Sector: Pharmaceutical / Biotechnology
CY Partners is partnering with a leading global pharmaceutical organisation to recruit a Global Real-World Evidence (RWE) & Health Outcomes Research (HOR) Analyst / Epidemiologist. This role sits within a mature, globally integrated RWE & HOR function and supports a strategic, late-stage / marketed priority asset across its lifecycle.
This opportunity is well suited to candidates with hands-on experience working in, or closely with, the pharmaceutical industry, who are looking to deepen their impact in global evidence generation.
Reporting directly to the Global RWE & HOR Lead, you will contribute to the development and execution of asset-level real-world evidence strategies aligned to regulatory, access, and medical needs. You will work cross-functionally within a complex global matrix, collaborating closely with Medical Affairs, HEOR, Clinical Development, Market Access, and external research partners.
Support asset-level RWE and HEOR strategy across development and/or lifecycle management
Contribute to the planning and delivery of Data Generation Plans (DGPs) aligned to regulatory, HTA, and payer evidence requirements
Design, execute, and oversee non-interventional studies (e.g. observational studies, registries, database studies)
Collaborate with internal stakeholders including Global Medical Affairs, HEOR, Market Access, Clinical, Biostatistics, and Regulatory
Manage and engage with external vendors, CROs, data owners, and academic collaborators
Support interpretation, scientific validation, and dissemination of RWE outputs (e.g. congresses, publications, internal decision-making)
Ensure studies meet internal governance, quality, and compliance standards typical of a global pharmaceutical organisation
MSc (or equivalent) in a relevant discipline, such as:
Health Outcomes Research
Health Economics
Epidemiology
Patient-Reported Outcomes
Pharmacy
Health or Life Sciences
Demonstrable experience within the pharmaceutical or biotechnology industry, or in a consultancy/CRO supporting pharma clients
Practical experience delivering RWE and/or non-interventional studies in an industry setting
Familiarity with regulatory, HTA, or payer evidence expectations
Strong ability to operate within global, cross-functional matrix teams
Excellent stakeholder management and scientific communication skills
This is an opportunity to work on a high-visibility global asset, contribute to evidence that directly informs regulatory, access, and medical strategy, and grow your career within a best-in-class pharmaceutical RWE & HEOR function.
For more information or a confidential discussion, please contact CY Partners.